Description

Rapimig (Zolmitriptan) Dispersible Tablets 5 mg. №6

Ingredients:

Each dispersible tablet contains 5 mg of zolmitriptan.

Dosage:

The recommended dosage is one tablet as needed. Do not exceed more than 10 mg in a 24-hour period.

Indications:

Rapimig (Zolmitriptan) is indicated for the acute treatment of migraine attacks with or without aura.

Contraindications:

Do not use Rapimig (Zolmitriptan) if you have uncontrolled hypertension, ischemic heart disease, or have used MAO inhibitors in the past 2 weeks.

Directions:

Place the tablet on your tongue, where it will disintegrate in your mouth. Swallow with saliva. No water is needed.

Scientific Evidence:

Zolmitriptan, the active ingredient in Rapimig, is a selective serotonin receptor agonist that works by constricting blood vessels in the brain, reducing inflammation, and blocking pain signals. Clinical trials have shown that zolmitriptan is effective in relieving migraine symptoms, including pain, nausea, and sensitivity to light and sound.

Research published in the journal Headache demonstrated the efficacy of zolmitriptan dispersible tablets in providing rapid relief from migraine attacks, with a significant number of patients experiencing pain relief within 2 hours of taking the medication.

Additional Information:

• Rapimig (Zolmitriptan) dispersible tablets offer a convenient and fast-acting option for migraine relief.
• Avoid driving or operating machinery until you know how this medication affects you.
• If your symptoms do not improve or worsen after taking Rapimig, consult a healthcare professional.